CDK inhibitor Centrinone-B, Purity ≥98%

Cat. No.: X24-05-ZQ717

CDK inhibitor Centrinone-B, Purity ≥98%

Synonym: 1798871-31-4; LCR-323; LCR323; LCR 323; CDK inhibitor

  • CAS Number: 1798871-31-4
  • Compound CID: 118704753
Product Size
5 mg; 10 mg; 50 mg; 100 mg
Price
Datasheet
MSDS
Properties
Description
Centrinone-B is an CDK kinase inhibitor that disrupts cell division processes. It targets Aurora A, Aurora B, PLK4, and PLK4 (G95L).
Molecular Weight
631.67
Molecular Formula
C27H27F2N7O5S2
Targets
Aurora A: 1239 nM (Ki); Aurora B: 5597.14 nM (Ki); PLK4: 0.59 nM (Ki); PLK4 (G95L): 497.53 nM (Ki)
Form
Lyophilized powder
Purity
≥98%
Identity
Confirmed by NMR/HPLC/MS.
Stability
The product is stable for three years when stored at the recommended temperature in lyophilized powder.
Applications
Centrinone-B is used to investigate its selective inhibition of Centrinone and its effects on centrosome duplication in cell cycle regulation.
Storage
Store at -20ºC.
Related Products

About Us

CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.

Contact Us

Copyright © CD BioGlyco. All rights reserved.